Brokerages predict that Mettler-Toledo International Inc. (NYSE:MTD) will report earnings of $6.74 per share for the current quarter, Zacks reports. Five analysts have issued estimates for Mettler-Toledo International’s earnings, with estimates ranging from $6.68 to $6.76. Mettler-Toledo International reported earnings per share of $5.97 during the same quarter last year, which indicates a positive year over year growth rate of 12.9%. The business is expected to report its next quarterly earnings results on Thursday, February 14th.

On average, analysts expect that Mettler-Toledo International will report full year earnings of $20.23 per share for the current fiscal year, with EPS estimates ranging from $20.20 to $20.27. For the next fiscal year, analysts anticipate that the company will post earnings of $22.50 per share, with EPS estimates ranging from $22.34 to $22.60. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Mettler-Toledo International.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $5.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.99 by $0.13. Mettler-Toledo International had a net margin of 14.10% and a return on equity of 93.15%. The company had revenue of $734.85 million during the quarter, compared to analysts’ expectations of $738.23 million. During the same quarter in the prior year, the company earned $4.36 EPS. The firm’s revenue was up 5.2% on a year-over-year basis.

MTD has been the subject of a number of recent analyst reports. Morgan Stanley upped their price target on shares of Mettler-Toledo International from $529.00 to $572.00 and gave the company an “equal weight” rating in a report on Wednesday, October 10th. UBS Group initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, October 9th. They set a “neutral” rating and a $625.00 price target for the company. Zacks Investment Research upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $621.00 price target for the company in a report on Friday, October 12th. Finally, ValuEngine upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Friday, November 16th. Ten research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $624.00.

In other Mettler-Toledo International news, insider William P. Donnelly sold 2,500 shares of the company’s stock in a transaction on Monday, November 19th. The shares were sold at an average price of $598.20, for a total value of $1,495,500.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Hans Ulrich Maerki sold 2,600 shares of the company’s stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $650.00, for a total transaction of $1,690,000.00. Following the completion of the transaction, the director now owns 9,487 shares of the company’s stock, valued at $6,166,550. The disclosure for this sale can be found here. Insiders have sold a total of 31,871 shares of company stock valued at $19,575,275 over the last quarter. 4.80% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Migdal Insurance & Financial Holdings Ltd. raised its holdings in Mettler-Toledo International by 143.2% in the 3rd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 180 shares of the medical instruments supplier’s stock worth $110,000 after purchasing an additional 106 shares in the last quarter. Captrust Financial Advisors raised its holdings in Mettler-Toledo International by 306.7% in the 2nd quarter. Captrust Financial Advisors now owns 183 shares of the medical instruments supplier’s stock worth $106,000 after purchasing an additional 138 shares in the last quarter. IFP Advisors Inc raised its holdings in Mettler-Toledo International by 603.7% in the 3rd quarter. IFP Advisors Inc now owns 190 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 163 shares in the last quarter. Point72 Hong Kong Ltd bought a new position in Mettler-Toledo International in the 3rd quarter worth $135,000. Finally, Piedmont Investment Advisors LLC bought a new position in Mettler-Toledo International in the 2nd quarter worth $167,000. Institutional investors and hedge funds own 93.80% of the company’s stock.

Shares of Mettler-Toledo International stock traded down $18.57 during trading on Friday, reaching $610.10. The company’s stock had a trading volume of 331,851 shares, compared to its average volume of 184,753. Mettler-Toledo International has a 52-week low of $521.79 and a 52-week high of $697.26. The stock has a market capitalization of $15.75 billion, a price-to-earnings ratio of 34.72, a price-to-earnings-growth ratio of 2.44 and a beta of 1.20. The company has a debt-to-equity ratio of 1.86, a quick ratio of 1.00 and a current ratio of 1.39.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

See Also: What is the balance sheet?

Get a free copy of the Zacks research report on Mettler-Toledo International (MTD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.